美股市场个股详情

SXTP 60 Degrees Pharmaceuticals

添加自选

0.220
-0.005-2.22%

收盘价 05/13 16:00 (美东)

0.213
-0.007-3.36%

盘后 17:37 (美东)

254.55万总市值-339市盈率TTM

60 Degrees Pharmaceuticals股票讨论区

登录发表评论

ProperMicheleV

05/04 01:05

$60 Degrees Pharmaceuticals(SXTP.US)$ This is my LOOooNnnG, oh so long stock that I hate looking at. I know the price will eventually go up. I have mentioned that I have the disease their patented med treats (babesiosis) & I know the # of people with the disease & # of ticks with the disease is underreported. I know this like I know birds fly, but it's going to take years before the general population knows it. BTW, their new patented med is the only medication that can fully erradicate babe...

Jaguar8

05/02 19:59

$60 Degrees Pharmaceuticals(SXTP.US)$
NEWS
60 Degrees Pharmaceuticals Receives FDA Comments on Tafenoquine-Babesiosis Clinical Trial Protocol; No Material Changes Required
60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) has received comments from the FDA on the protocol for a clinical trial studying tafenoquine in treating babesiosis, a life-threatening tick-borne disease. The comments do not require material changes to the trial design. The Company is moving forward with trial planning a...

after hours wild 😜 🤪 😅 card

$60 Degrees Pharmaceuticals(SXTP.US)$

60 Degrees Pharmaceuticals(SXTP) 0.288 +14.15%

Trytosaveabit

03/14 20:11

Update

$60 Degrees Pharmaceuticals(SXTP.US)$ 60 Degrees Pharmaceuticals, Inc., (NASDAQ:SXTP, SXTPW))))) ("60 Degrees Pharmaceuticals" or the "Company"), a pharmaceutical company focused on developing new medicines for infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has communicated its intention to send any comments regarding the Company's babesiosis trial within the month of April, 2024, rather than March, 2024 as anticipated by the Company. The protocol sub...

$60 Degrees Pharmaceuticals (SXTP.US)$ I started my trading journey with this stock. I have the disease their patented tanefoquine med treats. I believe the number of people that have it is underreported. also, Yale medicine & tufts are reporting that using tafenoquine will eradicate the disease/parasite completely, which current treatment does not. the disease is babesiosis aka American malaria. as well, it is my understanding that the fda is going to fast track meds for rare diseases, which ba...

暂无评论

分析

分析师评级

暂无数据

目标价预测

暂无数据

热议

美股

综合热度